1. |
T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. |
Amanatidou V, etal., Pediatr Infect Dis J. 2006 May;25(5):410-4.
|
2. |
Immunohistochemical detection of CCR2 and CX3CR1 in sepsis-induced lung injury. |
An JL, etal., Forensic Sci Int. 2009 Nov 20;192(1-3):e21-5. Epub 2009 Sep 4.
|
3. |
Association of sequence variation in the CX3CR1 gene with geographic atrophy age-related macular degeneration in a Greek population. |
Anastasopoulos E, etal., Curr Eye Res. 2012 Dec;37(12):1148-55. doi: 10.3109/02713683.2012.705413. Epub 2012 Jul 20.
|
4. |
Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. |
Andre F, etal., Ann Oncol. 2006 Jun;17(6):945-51. Epub 2006 Apr 20.
|
5. |
Chemokine receptors CCR2 and CX3CR1 regulate skin fibrosis in the mouse model of cytokine-induced systemic sclerosis. |
Arai M, etal., J Dermatol Sci. 2013 Mar;69(3):250-8. doi: 10.1016/j.jdermsci.2012.10.010. Epub 2012 Oct 24.
|
6. |
Impact of deficiency in CCR2 and CX3CR1 receptors on monocytes trafficking in herpes simplex virus encephalitis. |
Boivin N, etal., J Gen Virol. 2012 Jun;93(Pt 6):1294-304. doi: 10.1099/vir.0.041046-0. Epub 2012 Feb 29.
|
7. |
Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling. |
Briones TL, etal., J Neuroinflammation. 2014 Jan 22;11:13. doi: 10.1186/1742-2094-11-13.
|
8. |
Expression of chemokine receptor CX3CR1 in infants with respiratory syncytial virus bronchiolitis. |
Cepika AM, etal., Pediatr Allergy Immunol. 2008 Mar;19(2):148-56. doi: 10.1111/j.1399-3038.2007.00611.x.
|
9. |
Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. |
Chan CC, etal., Histol Histopathol. 2005 Jul;20(3):857-63.
|
10. |
Paraquat-induced retinal degeneration is exaggerated in CX3CR1-deficient mice and is associated with increased retinal inflammation. |
Chen M, etal., Invest Ophthalmol Vis Sci. 2013 Jan 23;54(1):682-90. doi: 10.1167/iovs.12-10888.
|
11. |
Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats. |
Chen YM, etal., Nephrol Dial Transplant. 2003 Dec;18(12):2505-14.
|
12. |
Expression of fractalkine (CX3CL1) and its receptor in endotoxin-induced uveitis. |
Chu L, etal., Ophthalmic Res. 2009;42(3):160-6. Epub 2009 Jul 31.
|
13. |
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. |
Combadiere C, etal., Circulation. 2003 Feb 25;107(7):1009-16.
|
14. |
CX3CR1-deficiency is associated with increased severity of disease in experimental autoimmune uveitis. |
Dagkalis A, etal., Immunology. 2009 Sep;128(1):25-33. doi: 10.1111/j.1365-2567.2009.03046.x.
|
15. |
CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation. |
Denoyer A, etal., Mucosal Immunol. 2012 Nov;5(6):702-11. doi: 10.1038/mi.2012.43. Epub 2012 Jun 13.
|
16. |
CX3CR1 polymorphisms are associated with atopy but not asthma in German children. |
Depner M, etal., Int Arch Allergy Immunol. 2007;144(1):91-4. Epub 2007 May 15.
|
17. |
Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation. |
Echigo T, etal., J Allergy Clin Immunol. 2004 May;113(5):940-8.
|
18. |
Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis. |
Fang IM, etal., Mol Vis. 2005 Jul 1;11:443-51.
|
19. |
Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. |
Feng L, etal., Kidney Int. 1999 Aug;56(2):612-20.
|
20. |
Study of Polymorphisms in CX3CR1, PLEKHA1 and VEGF Genes as Risk Factors for Age-related Macular Degeneration in Indian Patients. |
Gupta D, etal., Arch Med Res. 2014 Jul 19. pii: S0188-4409(14)00161-1. doi: 10.1016/j.arcmed.2014.07.005.
|
21. |
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. |
Harcourt J, etal., J Immunol. 2006 Feb 1;176(3):1600-8.
|
22. |
Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis. |
Hasegawa M, etal., Ann Rheum Dis. 2005 Jan;64(1):21-8.
|
23. |
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P. |
Haynes LM, etal., J Virol. 2003 Sep;77(18):9831-44.
|
24. |
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. |
Hughes PM, etal., Glia. 2002 Mar 15;37(4):314-27.
|
25. |
Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. |
Ito Y, etal., Kidney Int. 2002 Jun;61(6):2044-57.
|
26. |
Dual targeting of CCR2 and CX3CR1 in an arterial injury model of vascular inflammation. |
Jerath MR, etal., Thromb J. 2010 Sep 13;8:14. doi: 10.1186/1477-9560-8-14.
|
27. |
Expression of the chemokine fractalkine (FKN/CX3CL1) by podocytes in normal and proteinuric rat kidney glomerulus. |
Katsuyama K, etal., Nephron Exp Nephrol. 2009;113(2):e45-56. Epub 2009 Jul 10.
|
28. |
The effects of age and Cx3cr1 deficiency on retinal microglia in the Ins2(Akita) diabetic mouse. |
Kezic JM, etal., Invest Ophthalmol Vis Sci. 2013 Jan 30;54(1):854-63. doi: 10.1167/iovs.12-10876.
|
29. |
Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys. |
Kikuchi Y, etal., Nephron Exp Nephrol. 2004;97(1):e17-25.
|
30. |
Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK. |
Lee KM, etal., Eur J Pain. 2010 Aug;14(7):682.e1-12. Epub 2009 Dec 2.
|
31. |
mRNA expression of chemokine receptors on peripheral blood mononuclear cells and correlation with clinical features in systemic lupus erythematosus patients. |
Li YM, etal., Chin Med Sci J. 2010 Sep;25(3):162-8.
|
32. |
Protective roles of the fractalkine/CX3CL1-CX3CR1 interactions in alkali-induced corneal neovascularization through enhanced antiangiogenic factor expression. |
Lu P, etal., J Immunol. 2008 Mar 15;180(6):4283-91.
|
33. |
Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling. |
Luhmann UF, etal., PLoS One. 2012;7(4):e35551. doi: 10.1371/journal.pone.0035551. Epub 2012 Apr 24.
|
34. |
Spinal changes associated with mechanical hypersensitivity in a model of Guillain-Barre syndrome. |
Luongo L, etal., Neurosci Lett. 2008 May 30;437(2):98-102. Epub 2008 Apr 10.
|
35. |
Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. |
Marasini B, etal., Clin Dev Immunol. 2005 Dec;12(4):275-9.
|
36. |
Elevated serum levels of soluble CX3CL1 in patients with microscopic polyangiitis. |
Matsunawa M, etal., Clin Exp Rheumatol. 2009 Jan-Feb;27(1):72-8.
|
37. |
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. |
McDermott DH, etal., Circ Res. 2001 Aug 31;89(5):401-7.
|
38. |
Gut-brain chemokine changes in portal hypertensive rats. |
Merino J, etal., Dig Dis Sci. 2011 Aug;56(8):2309-17. doi: 10.1007/s10620-011-1625-y. Epub 2011 Feb 24.
|
39. |
MGDs mouse GO annotations |
MGD data from the GO Consortium
|
40. |
MGD IEA |
MGD IEA
|
41. |
An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. |
Milligan E, etal., Eur J Neurosci. 2005 Dec;22(11):2775-82.
|
42. |
CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. |
Mionnet C, etal., Nat Med. 2010 Nov;16(11):1305-12. Epub 2010 Oct 31.
|
43. |
Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition. |
Morimura S, etal., Am J Pathol. 2013 May;182(5):1640-7. doi: 10.1016/j.ajpath.2013.01.023. Epub 2013 Mar 5.
|
44. |
Predominant infiltration of monocytes in chronic graft-versus-host disease. |
Namba N, etal., Transplantation. 2007 Jan 27;83(2):220-4.
|
45. |
Polymorphisms of immunity genes and susceptibility to otitis media in children. |
Nokso-Koivisto J, etal., PLoS One. 2014 Apr 9;9(4):e93930. doi: 10.1371/journal.pone.0093930. eCollection 2014.
|
46. |
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. |
Okazaki Y, etal., Nature. 2002 Dec 5;420(6915):563-73.
|
47. |
OMIM Disease Annotation Pipeline |
OMIM Disease Annotation Pipeline
|
48. |
Intrathecal infusion of pyrrolidine dithiocarbamate for the prevention and reversal of neuropathic pain in rats using a sciatic chronic constriction injury model. |
Pan YD, etal., Reg Anesth Pain Med. 2010 May-Jun;35(3):231-7. doi: 10.1097/AAP.0b013e3181df245b.
|
49. |
Changes in spinal cord expression of fractalkine and its receptor in a rat model of disc herniation by autologous nucleus pulposus. |
Park HW, etal., Spine (Phila Pa 1976). 2011 Jan 8.
|
50. |
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension. |
Perros F, etal., Eur Respir J. 2007 May;29(5):937-43. Epub 2006 Dec 20.
|
51. |
The CX3CL1-CX3CR1 system and psoriasis. |
Plant D, etal., Exp Dermatol. 2006 Nov;15(11):900-3.
|
52. |
Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation. |
Pong WW, etal., Ann Neurol. 2013 Feb;73(2):303-8. doi: 10.1002/ana.23813. Epub 2013 Feb 19.
|
53. |
Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice. |
Poupel L, etal., Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2297-305. doi: 10.1161/ATVBAHA.112.300930. Epub 2013 Jul 25.
|
54. |
Upregulation of chemokine receptor gene expression in brains of Borna disease virus (BDV)-infected rats in the absence and presence of inflammation. |
Rauer M, etal., J Neurovirol. 2002 Jan;8(3):168-79.
|
55. |
Mouse MP Annotation Import Pipeline |
RGD automated import pipeline
|
56. |
Data Import for Chemical-Gene Interactions |
RGD automated import pipeline for gene-chemical interactions
|
57. |
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis. |
Ridderstad Wollberg A, etal., Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5409-14. doi: 10.1073/pnas.1316510111. Epub 2014 Mar 25.
|
58. |
The cardiovascular actions of fractalkine/CX3CL1 in the hypothalamic paraventricular nucleus are attenuated in rats with heart failure. |
Ruchaya PJ, etal., Exp Physiol. 2014 Jan;99(1):111-22. doi: 10.1113/expphysiol.2013.075432. Epub 2013 Sep 13.
|
59. |
Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. |
Ruth JH, etal., Arthritis Rheum. 2001 Jul;44(7):1568-81.
|
60. |
Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation. |
Sbrana S, etal., Cytometry B Clin Cytom. 2005 May;65(1):14-21.
|
61. |
CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice. |
Sennlaub F, etal., EMBO Mol Med. 2013 Nov;5(11):1775-93. doi: 10.1002/emmm.201302692. Epub 2013 Oct 21.
|
62. |
NEW evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease. |
Shan S, etal., Neurobiol Aging. 2009 Apr 14.
|
63. |
Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity. |
Sirois-Gagnon D, etal., Obesity (Silver Spring). 2011 Jan;19(1):222-7. Epub 2010 Jun 3.
|
64. |
Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice. |
Staniland AA, etal., J Neurochem. 2010 Aug;114(4):1143-57. doi: 10.1111/j.1471-4159.2010.06837.x. Epub 2010 May 28.
|
65. |
CX(3)CL1 (fractalkine) and its receptor CX(3)CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin. |
Staumont-Salle D, etal., J Exp Med. 2014 Jun 2;211(6):1185-96. doi: 10.1084/jem.20121350. Epub 2014 May 12.
|
66. |
[Effects of aspirin on CX3CL1 and CX3CR1 in acute pulmonary embolism rats]. |
Sun C, etal., Zhonghua Yi Xue Za Zhi. 2013 Jan 1;93(1):69-72.
|
67. |
Inhibition of the Activation and Recruitment of Microglia-Like Cells Protects Against Neomycin-Induced Ototoxicity. |
Sun S, etal., Mol Neurobiol. 2014 May 1.
|
68. |
New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis. |
Sun S, etal., Pain. 2007 May;129(1-2):64-75. Epub 2006 Nov 22.
|
69. |
CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. |
Sunnemark D, etal., J Neuroinflammation. 2005 Jul 29;2:17.
|
70. |
Association study between the CX3CR1 gene and asthma. |
Tremblay K, etal., Genes Immun. 2006 Dec;7(8):632-9. Epub 2006 Nov 2.
|
71. |
The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. |
Tuo J, etal., FASEB J. 2004 Aug;18(11):1297-9. Epub 2004 Jun 18.
|
72. |
Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. |
Tuo J, etal., Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3827-36.
|
73. |
Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. |
Verge GM, etal., Eur J Neurosci 2004 Sep;20(5):1150-60.
|
74. |
A CX3CR1 genotype associated with retinal vasculitis in patients in the United Kingdom. |
Wallace GR, etal., Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2966-70.
|
75. |
Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model. |
Wang K, etal., Glia. 2014 Jul 2. doi: 10.1002/glia.22715.
|
76. |
A functional relationship between trigeminal astroglial activation and NR1 expression in a rat model of temporomandibular joint inflammation. |
Wang S, etal., Pain Med. 2012 Dec;13(12):1590-600. doi: 10.1111/j.1526-4637.2012.01511.x. Epub 2012 Oct 30.
|
77. |
Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling. |
Willemen HL, etal., Pain. 2010 Sep;150(3):550-60. Epub 2010 Jul 6.
|
78. |
Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. |
Wu J, etal., Neurobiol Aging. 2013 Dec;34(12):2843-52. doi: 10.1016/j.neurobiolaging.2013.06.003. Epub 2013 Jul 12.
|
79. |
Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats. |
Yang JL, etal., Mol Brain. 2012 May 30;5:18. doi: 10.1186/1756-6606-5-18.
|
80. |
The roles of fractalkine/CX3CR1 system in neuronal death following pilocarpine-induced status epilepticus. |
Yeo SI, etal., J Neuroimmunol. 2011 May;234(1-2):93-102. doi: 10.1016/j.jneuroim.2011.03.005. Epub 2011 Apr 8.
|
81. |
Intrathecal injection of anti-CX3CR1 neutralizing antibody delayed and attenuated pain facilitation in rat tibial bone cancer pain model. |
Yin Q, etal., Behav Pharmacol. 2010 Oct;21(7):595-601.
|
82. |
Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis. |
Yuridullah R, etal., Auton Neurosci. 2006 Jun 30;126-127:380-9. Epub 2006 May 2.
|
83. |
The role of CX(3)CL1/CX(3)CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. |
Zhang J, etal., J Hepatol. 2012 Oct;57(4):752-8. doi: 10.1016/j.jhep.2012.05.014. Epub 2012 May 29.
|